Brinker Capital Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

Brinker Capital Investments’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-37,000	Closed	-$3.42M	–	1279
2021 Q2	$3.42M	Sell	37,000 -20,000	-35%	-$1.7M	0.05%	420
2021 Q1	$5.06M	Sell	57,000 -18,000	-24%	-$1.79M	0.08%	265
2020 Q4	$7M	Buy	+75,000	New	+$5.98M	0.11%	223
2020 Q3	–	Sell	-152,000	Closed	-$7.93M	–	1143
2020 Q2	$7.93M	Sell	152,000 -15,000	-9%	-$643K	0.33%	72
2020 Q1	$5.22M	Hold	167,000	–	–	0.24%	96
2019 Q4	$5.6M	Buy	+167,000	New	+$5.31M	0.19%	111

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Brinker Capital Investments's ARKG Position: Q3 2021 in Review

Brinker Capital Investments sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 37,000 shares — an estimated $3.42M sold.

Brinker Capital Investments first reported a position in ARKG in Q4 2019 and held it in 6 quarters. The position peaked at $7.93M in Q2 2020. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

Brinker Capital Investments reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
Brinker Capital Investments sold 37,000 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $3.42M.
Brinker Capital Investments first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 6 quarters.
Brinker Capital Investments's ARK Genomic Revolution ETF position peaked at $7.93M in Q2 2020.
468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Brinker Capital Investments's 13F filing for Q3 2021, filed 8 Nov 2021.